Breaking News
Get 45% Off 0
Selloff or market correction? Either way, here's what to do next
See Overvalued Stocks

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
4 Technology Stocks In The Spotlight Ahead Of Thanksgiving By Zacks Investment Research - Nov 20, 2017

Thanksgiving Day (Nov 23) that marks the beginning of the month-long holiday season is just a few days away. Most Americans wait for the fourth Thursday of November every year to begin shopping for...

Zacks Investment Research
Associated Banc-Corp Outlook Upgraded To Stable By Moody's By Zacks Investment Research - Nov 20, 2017

Associated Banc-Corp’s (NYSE:ASB) ratings outlook has been upgraded to stable from negative by Moody's Investors Service, a rating arm of Moody's Corporation (NYSE:MCO) . The rating agency...

Zacks Investment Research
Campbell (CPB) Misses On Q1 Earnings & Sales, Stock Down 8% By Zacks Investment Research - Nov 20, 2017

Campbell Soup Company (NYSE:CPB) posted first-quarter fiscal 2018 results, wherein both earnings and sales missed the Zacks Consensus Estimate and declined year over year. This marks the third...

Zacks Investment Research
Vipshop (VIPS) Misses Q3 Earnings, Sales Beat Estimates By Zacks Investment Research - Nov 20, 2017

Vipshop Holdings Limited (NYSE:VIPS) posted mixed third-quarter 2017 results, with revenues surpassing the Zacks Consensus Estimate and earnings missing the same by a penny. This is the second...

Zacks Investment Research
Medtronic (MDT) Beats On Q2 Earnings, Reiterates FY18 View By Zacks Investment Research - Nov 20, 2017

Medtronic plc (NYSE:MDT) reported second-quarter fiscal 2018 adjusted earnings per share (EPS) of $1.07, beating the Zacks Consensus Estimate by 8.1%. Earnings however declined 4.5% year over year....

Zacks Investment Research
Armstrong World (AWI) To Sell EMEA & Pacific Rim Businesses By Zacks Investment Research - Nov 20, 2017

Shares of Armstrong World Industries, Inc. (NYSE:AWI) gained nearly 7% to close at $53.85 on Nov 20, after the company declared that it has signed a definitive agreement to divest its EMEA (Europe,...

Zacks Investment Research
Mohawk (MHK) To Buy Godfrey Hirst, Boost Global Presence By Zacks Investment Research - Nov 20, 2017

Mohawk Industries, Inc. (NYSE:MHK) recently entered into an agreement to acquire a leading flooring company in Australia and New Zealand, Godfrey Hirst Group. The deal is expected to close in the...

Zacks Investment Research
Alnylam's RNAi Candidate Gains Breakthrough Therapy Status By Zacks Investment Research - Nov 20, 2017

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) announced that the FDA has granted Breakthrough Therapy Designation for lead candidate, patisiran. The candidate is an investigational RNAi therapeutic...

Zacks Investment Research
Dept. Of Justice Sues To Stop AT&T, Time Warner Deal By Zacks Investment Research - Nov 20, 2017

Tuesday, November 21, 2017So the rhetoric appears to have actions backing it up, after all: upon the event of a massive $85.4 billion merger between AT&T (NYSE:T) and Time Warner (NYSE:TWX) ,...

Zacks Investment Research
Earthstone Divests Bakken Assets To Focus On Midland Basin By Zacks Investment Research - Nov 20, 2017

Upstream energy company Earthstone Energy, Inc. (NYSE:ESTE) has agreed to divest its Bakken assets for around $27 million in an all-cash deal. Per the company, the effective date is Dec 1. The deal...

Zacks Investment Research
Primoris Unit Secures $27M Industrial Contract From A Client By Zacks Investment Research - Nov 20, 2017

ARB Underground, a unit of Primoris Services Corporation (NASDAQ:PRIM) , has won a new industrial contract worth $27 million from a refiner. Per the deal, Primoris is likely to perform mechanical,...

Zacks Investment Research
AMD Processor Powered Hewlett Packard Servers Set Record By Zacks Investment Research - Nov 20, 2017

Advanced Micro Devices Inc. (NASDAQ:AMD) recently announced that Hewlett Packard Enterprise’s (NYSE:HPE) new ProLiant DL385 Gen10 server, which is powered by AMD’s EPYC processor has...

Zacks Investment Research
TESARO (TSRO) Ovarian Cancer Drug Zejula Gets Approval In EU By Zacks Investment Research - Nov 20, 2017

TESARO, Inc. (NASDAQ:TSRO) announced that the European Commission has granted marketing authorization to its PARP inhibitor, Zejula, as monotherapy for the maintenance treatment of women with...

Zacks Investment Research
Dean Foods' (DF) Shares Decline 44% In 6 Months: Here's Why By Zacks Investment Research - Nov 20, 2017

Dean Foods Company (NYSE:DF) has been struggling with higher raw milk costs and lower volumes for quite some time now. Also, a tough retail scenario that is characterized by fast-evolving consumer...

Zacks Investment Research
Here's Why You Should Add Fortive (FTV) To Your Portfolio By Zacks Investment Research - Nov 20, 2017

Fortive Corporation (NYSE:FTV) is currently a well-performing technology stock and a rise in share price and strong fundamentals signal its bullish run. Therefore, if you haven’t taken...

Continue with Apple
Continue with Google
or
Sign up with Email